Search research articles
Contact Us
Filters
Showing results (141-150 of 327) with videos related to
Page
of 33
Sort By:
Journal of the American Academy of Dermatology
|
February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
The Oncologist
|
June 14, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer
Ryan J Sullivan, Oladapo O Yeku, Deanna Teoh, et al.
Cancer
|
December 7, 2018
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy
Karim R Saab, Meghan J Mooradian, Daniel Y Wang, et al.
Nature Medicine
|
August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Noam Auslander, Gao Zhang, Joo Sang Lee, et al.
JCO Oncology Practice
|
July 22, 2024
Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study
Mary C Boulanger, Ayo S Falade, Kelly Hsu, et al.
Journal for Immunotherapy of Cancer
|
May 3, 2023
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
Tian Zhang, Patrick M Forde, Ryan J Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Advances in Radiation Oncology
|
January 23, 2024
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
Alicia C Smart, Anita Giobbie-Hurder, Vineet Desai, et al.
Neurology
|
August 14, 2019
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
Divyanshu Dubey, William S David, Anthony A Amato, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 2, 2019
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy, Sophia Zhao, Donald F Chute, et al.
Page
of 33
Search research articles
Search
Showing results (141-150 of 327) with videos related to
Sort By:
Page
of 33
Journal of the American Academy of Dermatology
|
February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
The Oncologist
|
June 14, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer
Ryan J Sullivan, Oladapo O Yeku, Deanna Teoh, et al.
Cancer
|
December 7, 2018
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy
Karim R Saab, Meghan J Mooradian, Daniel Y Wang, et al.
Nature Medicine
|
August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Noam Auslander, Gao Zhang, Joo Sang Lee, et al.
JCO Oncology Practice
|
July 22, 2024
Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study
Mary C Boulanger, Ayo S Falade, Kelly Hsu, et al.
Journal for Immunotherapy of Cancer
|
May 3, 2023
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
Tian Zhang, Patrick M Forde, Ryan J Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Advances in Radiation Oncology
|
January 23, 2024
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
Alicia C Smart, Anita Giobbie-Hurder, Vineet Desai, et al.
Neurology
|
August 14, 2019
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
Divyanshu Dubey, William S David, Anthony A Amato, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 2, 2019
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy, Sophia Zhao, Donald F Chute, et al.
Page
of 33